Navigation Links
CMV Infection in Transplant Recipients: Clinical Cases and Expert Opinion
Date:12/15/2008

A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals

VOORHEES, N.J., Dec. 15 /PRNewswire/ -- Cytomegalovirus (CMV) infection is a serious condition and an important cause of morbidity and mortality in recipients of hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT). Controversy exists regarding the best method for CMV prevention. It is important for healthcare professionals working with transplant recipients to be aware of the advantages and limitations of the current strategies available for managing CMV infection and disease in this population.

To address the need for current education on CMV infection in transplant recipients, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture for physicians, pharmacists, nurses, and other infectious disease specialists. This activity is supported by an educational grant from ViroPharma Incorporated.

Faculty for this virtual lecture include Michael J. Boeckh, MD, Associate Member of the Program of Infectious Diseases at Fred Hutchinson Cancer Research Center and Associate Professor at the University of Washington School of Medicine in Seattle, Washington; John R. Wingard, MD, Professor and Price Chair of Medicine in the Department of Pediatrics and Director of the Blood and Bone Marrow Transplant Program at the University of Florida Shands Cancer Center in Gainesville, Florida; Raymund R. Razonable, MD, Assistant Professor of Medicine at the Mayo Clinic College of Medicine in Rochester, Minnesota; and Ajit P. Limaye, MD, Associate Professor of Laboratory Medicine and Co-Director of the Clinical Microbiology Laboratory and Director of the Organ Transplant Infectious Diseases Program at the University of Washington Medical Center in Seattle, Washington.

<
'/>"/>

SOURCE Robert Michael Educational Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
3. Computers help chemists fight emerging infections
4. Infection contributes to the high rates of oropharyngeal cancers
5. Jefferson immunology researchers halt lethal rabies infection in brain
6. SIV infection of natural hosts provides new insights into HIV disease complexity
7. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
8. Natural aorta grafts have few side effects for infection-prone patients
9. Common misdiagnosis: most women believe they have a yeast infection when they dont
10. Patient Safety Authority Board of Directors Names Infection Advisory Panel
11. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Patient-centered approach to capturing data from cancer patients improves care and research 2Health News:Gene signature may predict patient response to therapy for gastrointestinal stromal tumors 2Health News:Ginger Eases Nausea From Chemo 2Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 2Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 3Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 2Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 3Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 4Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 5Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 6Health News:MedServe to be Acquired by Stericycle for $185 Million 2Health News:MedServe to be Acquired by Stericycle for $185 Million 3
Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3Concord Coalition Releases Issue Brief on Administrations IMAC Proposal 53399 1Concord Coalition Releases Issue Brief on Administrations IMAC Proposal 53399 2August 2009 Geology and GSA Today media highlights 9447 1August 2009 Geology and GSA Today media highlights 9447 2August 2009 Geology and GSA Today media highlights 9447 3August 2009 Geology and GSA Today media highlights 9447 4August 2009 Geology and GSA Today media highlights 9447 5August 2009 Geology and GSA Today media highlights 9447 6August 2009 Geology and GSA Today media highlights 9447 7August 2009 Geology and GSA Today media highlights 9447 8August 2009 Geology and GSA Today media highlights 9447 9August 2009 Geology and GSA Today media highlights 9447 10August 2009 Geology and GSA Today media highlights 9447 11August 2009 Geology and GSA Today media highlights 9447 12August 2009 Geology and GSA Today media highlights 9447 13August 2009 Geology and GSA Today media highlights 9447 14August 2009 Geology and GSA Today media highlights 9447 15BBV Vietnam S E A Acquisition Corp Announces Signing of Letter of Intent for Business Combination with Migami Inc 53392 1BBV Vietnam S E A Acquisition Corp Announces Signing of Letter of Intent for Business Combination with Migami Inc 53392 2